<乌鸦传媒>Leading Causes of Death Hit Childhood Cancer Survivors Earlier But excess risk lowest in survivors with a healthy lifestyle Apr 06, 2023
<乌鸦传媒>CAR T-Cell Therapy Feasible, Safe in Advanced Neuroblastoma ORR of 63% with GD2-targeting product in kids with relapsed, refractory high-risk disease Apr 06, 2023
<乌鸦传媒>Major Survival Gain With Immunotherapy in Lymphomatoid Granulomatosis Median overall survival reached 20 years with interferon alfa-2b in low-grade disease Apr 05, 2023
<乌鸦传媒>Does Your 80-Year-Old Patient Really Need That Colonoscopy? Physicians often ignore life expectancy in screening decisions, study finds Apr 04, 2023
<乌鸦传媒>FDA Greenlights New First-Line Regimen in Bladder Cancer Enfortumab vedotin plus pembrolizumab approved for cisplatin-ineligible patients Apr 04, 2023
<乌鸦传媒>Post-Immunotherapy Combo Promising in Advanced RCC Duration of response reaches 18.6 months with belzutifan plus cabozantinib Apr 03, 2023
<乌鸦传媒>VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapy Prospective study in heavily treated population is warranted, researcher says Mar 30, 2023
<乌鸦传媒>Obesity's Impact on Uterine Cancer Risk Greater in Younger Age Groups Overall risk and risk of endometrioid subtype 20- to 30-fold greater in women younger than 35 Mar 30, 2023
<乌鸦传媒>A 'Double Whammy' for Gastric Cancer Risk H. pylori infection and certain pathogenic variants linked with large excess risk Mar 29, 2023
<乌鸦传媒>Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer Adding immunotherapy will change frontline treatment, experts say Mar 28, 2023
<乌鸦传媒>Novel Strategies Show Winning Potential in Ovarian Cancer High response rates in small studies of immuno-oncology combination, neoadjuvant olaparib Mar 28, 2023
<乌鸦传媒>High Out-of-Pocket Costs Tied to Less Follow-Up After Initial Mammography Plans dominated by copays and deductibles are associated with higher out-of-pocket costs Mar 27, 2023
<乌鸦传媒>No Survival Benefit With CRT Versus Chemo for Locally Advanced Endometrial Cancer Long-running clinical trial failed to identify any subgroup that fared better with CRT Mar 27, 2023
<乌鸦传媒>FDA Greenlights First Drug for Rare Immunodeficiency Disease Activated PI3K-delta syndrome may have a new standard of care Mar 27, 2023
<乌鸦传媒>Make the Diagnosis: This Bump on His Nose is a Tricky Diagnosis A 52-year-old man visited his doctor for a new growth on his nose. Can you diagnosis the patient? Mar 27, 2023
<乌鸦传媒>CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer Pathologic response rises to 73% versus 50% in historical control group Mar 27, 2023
<乌鸦传媒>CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancer Responses in a fourth of patients, clinical benefit in up to 90% Mar 26, 2023
<乌鸦传媒>Sam Neill's Rare Lymphoma The actor noticed swollen glands while on tour for "Jurassic World Dominion" Mar 23, 2023
<乌鸦传媒>Progestin-Only Birth Control Linked to Small Increase in Breast Cancer Risk But risk is similar to combined hormonal contraceptive use Mar 22, 2023
<乌鸦传媒>FDA OKs Another PD-1 Inhibitor for Merkel Cell Carcinoma Retifanlimab produced responses in 52% of patients with untreated unresectable disease Mar 22, 2023
<乌鸦传媒>Cancer Transmission From Organ Donors With Brain Tumors Not Much of a Risk In U.K. cohort study, no cases of transmission observed Mar 22, 2023
<乌鸦传媒>Sickle Cell Disease Patients Miss Out on Decades of Life What effects might emerging therapies have on real-world survival? Mar 17, 2023
<乌鸦传媒>FDA Allows Lower Risk Designation for Snuff Product The brand joins a limited few granted modified risk tobacco claims Mar 16, 2023
<乌鸦传媒>Laparoscopy, Surgery in a Draw for Gastric Cancer Survival Laparoscopy-assisted distal gastrectomy noninferior for both relapse-free, overall survival Mar 15, 2023
<乌鸦传媒>Take Risk Into Account Before Repeat Surveillance Colonoscopy, Study Says 58% of seniors with limited life expectancy, no significant findings invited for another round Mar 14, 2023
<乌鸦传媒>Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancers ZIRCON trial meets sensitivity and specificity targets Mar 13, 2023
<乌鸦传媒>FDA Panel Endorses New First-Line Lymphoma Regimen POLARIX trial supports a favorable risk-benefit profile for polatuzumab vedotin, ODAC members say Mar 10, 2023
<乌鸦传媒>Focus on Optimizing Use of CDK4/6 Inhibitors in Metastatic HR+ Breast Cancer Choice of agent, post-progression treatment, and resistance mechanisms top unanswered questions Mar 08, 2023
<乌鸦传媒>Understanding of HER2-Low Breast Cancer Continues to Evolve New breast cancer subtype proves challenging to define molecularly, pathologically, clinically Mar 07, 2023
<乌鸦传媒>FDA Not Quite Sold on Polivy in Frontline Large B-Cell Lymphoma Regimen Ahead of ODAC meeting, agency reviewers suggest modest PFS results in POLARIX "raise uncertainty" Mar 07, 2023
<乌鸦传媒>A Space for Mystery Elisha Waldman, MD, discusses faith and spirituality in medicine Mar 07, 2023 podcast
<乌鸦传媒>Full-Dose Anticoagulation Again Favored for COVID Admissions Despite failures, FREEDOM trial supports mortality advantage in general ward use Mar 07, 2023
<乌鸦传媒>KRAS Mutations in Metastatic CRC Predict Survival Benefit of Chemo Combo Trifluridine/tipiracil fails to improve survival in patients with KRAS G12-mutant tumors Mar 06, 2023
<乌鸦传媒>Cases of Breast Implant-Associated Lymphoma Continue to Accumulate More than 1,300 cases and 35 deaths, as reports of other implant-linked malignancies emerge Mar 06, 2023
<乌鸦传媒>'Our Goal Is Not to Omit Radiation Therapy' in Breast Cancer Honing indications for de-escalation of treatment intensity and, yes, selective omission of RT Mar 06, 2023
<乌鸦传媒>Antibody-Drug Conjugates Take Breast Cancer Field by Storm Established role in metastatic disease, may eventually replace chemotherapy Mar 04, 2023
<乌鸦传媒>Atorvastatin Tied to Cardioprotection for Lymphoma Patients on Anthracyclines STOP-CA deemed "an impactful study that will lead to more prescription of statins in patients." Mar 04, 2023
<乌鸦传媒>These Surgeries Made the Sharpest Turns to Outpatient Setting After COVID Several procedures saw significant increases in outpatient volumes Mar 03, 2023
<乌鸦传媒>'Winners' and 'Losers'; Mandated Sick Leave and Cancer Screening; More AI Advances News, features, and commentary about cancer-related issues Mar 03, 2023
<乌鸦传媒>Cancer-Free Medicare Recipients Received Fentanyl Indicated for Cancer Pain These prescriptions could lead to abuse, OIG report warns Mar 02, 2023
